IM Cannabis Corp. (IMCC) vs Propanc Biopharma, Inc. (PPCB)

A side-by-side comparison of IM Cannabis Corp. and Propanc Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

IMCC

IM Cannabis Corp.

$1M

$1.86HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT

PPCB

Propanc Biopharma, Inc.

$1M

$0.53HealthcareDelayed quote: Oct 6, 2026, 2:12 PM EDT

Total return — IMCC vs PPCB

growth of $100 · dividends reinvested · last 5y

IMCC -98.9% (-59.3%/yr)PPCB -100.0% (-83.9%/yr)IMCC compounded faster over this window

Log scale — wide-divergence pair

IMCC PPCB

IMCC vs PPCB: by the numbers

•PPCB is the larger company ($1M vs $1M market cap).
•Both run net losses; PPCB's is the smaller (0.00% vs -38.08% net margin).

Metrics side by side

Valuation

Metric	IMCC	PPCB
P/S ratio	0.04	N/A
P/B ratio	N/A	0.13

Profitability

Metric	IMCC	PPCB
Gross margin	13.74%	0.00%
Operating margin	-25.95%	0.00%
Net margin	-38.08%	0.00%
ROE	N/A	-200.63%
ROIC	-128.95%	-183.49%

Growth (annualized)

Metric	IMCC	PPCB
Revenue CAGR (5Y)	4.19%	N/A
Total return CAGR (5Y)	-80.08%	N/A

Go deeper

Full IMCC analysis Full PPCB analysis Interactive comparison tool

Dig into the metrics

IM Cannabis ROE Propanc Biopharma ROE IM Cannabis operating margin Propanc Biopharma operating margin IM Cannabis revenue growth Propanc Biopharma revenue growth IM Cannabis free cash flow Propanc Biopharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.